{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:36:30Z","timestamp":1793982990175,"version":"4.8.0"},"reference-count":109,"publisher":"Rambam Health Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"abstract":"<jats:p>Alternating hemiplegia of childhood (AHC) is a complex neurodevelopmental disorder characterized by paroxysmal and transient events of unilateral or bilateral paresis, usually occurring before 18 months of age. Mutations in the ATP1A3 gene, mainly p.Asp801Asn, p.Glu815Lys, and p.Gly947Arg at the protein level, are found in around 80% of the individuals with AHC. Interestingly, these mutations reflect the degree of severity of the neurological symptoms (p.Glu815Lys &gt; p.Asp801Asn &gt; p.Gly947Arg). Some channels involved in this disorder are N-type voltage-gated calcium channels, ATP-sensitive potassium channels, and the sodium\/calcium exchanger. In this context, the management of AHC should be divided into the treatment of attacks, prophylactic treatment, and management of comorbidities commonly found in this group of individuals, including epilepsy, attention-deficit\/hyperactivity disorder, aggressive behavior, cognitive impairment, movement disorders, and migraine. The importance of an integrated approach with a multidisciplinary team, such as neuropsychologists and dietitians, is worth mentioning, as well as the follow-up with a neurologist. In the present study, we propose new diagnostic criteria for AHC, dividing it into clinical, laboratory, supporting, and atypical features. Also, we review the location of the mutations in the ATP1A3 protein of individuals with AHC, rapid-onset dystonia-parkinsonism (RDP) variants, and early infantile epileptic encephalopathy (variants with hemiplegic attack). We also include a section about the animal models for ATP1A3 disorders.<\/jats:p>","DOI":"10.5041\/rmmj.10529","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T08:45:47Z","timestamp":1722329147000},"page":"e0015","source":"Crossref","is-referenced-by-count":9,"title":["Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review"],"prefix":"10.5041","volume":"15","author":[{"name":"Neurology Department, Cooper University Hospital, Camden, New Jersey, USA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamir Pitton","family":"Rissardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilorfar Murtaza","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medicine Department, Terna Speciality Hospital and Research Centre, Navi Mumbai, India","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medicine Department, Terna Speciality Hospital and Research Centre, Navi Mumbai, Indi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medicine Department, Terna Speciality Hospital and Research Centre, Navi Mumbai, Indi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Let\u00edcia Fornari","family":"Caprara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medicine Department, Federal University of Santa Maria, Santa Maria, Brazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0887-8994(00)00157-0","article-title":"Alternating hemiplegia of childhood: clinical manifestations and long-term outcome","volume":"23","author":"Mikati","year":"2000","unstructured":"1. Mikati MA, Kramer U, Zupanc ML, Shanahan RJ. Alternating hemiplegia of childhood: clinical manifestations and long-term outcome. Pediatr Neurol 2000;23:134-41.","journal-title":"Pediatr Neurol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejpn.2011.08.006","article-title":"Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients","volume":"16","author":"Fons","year":"2012","unstructured":"2. Fons C, Campistol J, Panagiotakaki E, et al. Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients. Eur J Paediatr Neurol 2012;16:10-14.","journal-title":"Eur J Paediatr Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejpn.2013.08.007","article-title":"Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status","volume":"18","author":"Hoei-Hansen","year":"2014","unstructured":"3. Hoei-Hansen CE, Dali C\u00cd, Lyngbye TJB, Duno M, Uldall P. Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status. Eur J Paediatr Neurol 2014;18:50-4.","journal-title":"Eur J Paediatr Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/epi.12878","article-title":"Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization","volume":"56","author":"Hunanyan","year":"2015","unstructured":"4. Hunanyan AS, Fainberg NA, Linabarger M, et al. Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization. Epilepsia 2015;56:82-93.","journal-title":"Epilepsia"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sweney MT, Silver K, Gerard-Blanluet M, et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 2009;123:e534-41.","DOI":"10.1542\/peds.2008-2027"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/B978-0-444-52910-7.00001-5","article-title":"Alternating hemiplegia of childhood","volume":"112","author":"Kansagra","year":"2013","unstructured":"6. Kansagra S, Mikati MA, Vigevano F. Alternating hemiplegia of childhood. Handb Clin Neurol 2013; 112:821-6.","journal-title":"Handb Clin Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0022-3476(06)80003-X","article-title":"Alternating hemiplegia of childhood","volume":"122","author":"Bourgeois","year":"1993","unstructured":"7. Bourgeois M, Aicardi J, Gouti\u00e8res F. Alternating hemiplegia of childhood. J Pediatr 1993;122:673-9.","journal-title":"J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0883073811436249","article-title":"An 11-year follow-up study of neonatal-onset, bath-induced alternating hemiplegia of childhood in twins","volume":"27","author":"Incorpora","year":"2012","unstructured":"8. Incorpora G, Pavone P, Polizzi A, et al. An 11-year follow-up study of neonatal-onset, bath-induced alternating hemiplegia of childhood in twins. J Child Neurol 2012;27:657-62.","journal-title":"J Child Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0387-7604(12)80144-6","article-title":"Alternating hemiplegia in childhood: 23 cases in Japan","volume":"14","author":"Sakuragawa","year":"1992","unstructured":"9. Sakuragawa N. Alternating hemiplegia in childhood: 23 cases in Japan. Brain Dev 1992;14:283-8.","journal-title":"Brain Dev"},{"key":"ref9","unstructured":"10. Aicardi J, Bourgeois M, Goutieres F. Alternating Hemiplegia of Childhood: Clinical Findings and Diagnostic Criteria. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:3-18."},{"key":"ref10","unstructured":"11. Bourgeois M. Alternating Hemiplegia of Childhood. A Report of 29 Cases and a Review of the Literature. In: Arzimanoglu A, Gouti\u00e8res F, eds. Trends in Child Neurology. London: John Libbey Eurotext; 1996: 163-8."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/dmcn.13443","article-title":"Motor function domains in alternating hemiplegia of childhood","volume":"59","author":"Masoud","year":"2017","unstructured":"12. Masoud M, Gordon K, Hall A, et al. Motor function domains in alternating hemiplegia of childhood. Dev Med Child Neurol 2017;59:822-8.","journal-title":"Dev Med Child Neurol"},{"key":"ref12","unstructured":"13. Bursztyn J, Mikaeloff Y, Kaminska A, et al. [Alternating hemiplegia of childhoood and oculomotor anomalies]. J Fr Ophtalmol 2000;23:161-4. [Article in French] https:\/\/pubmed.ncbi.nlm.nih.gov\/10705111\/"},{"key":"ref13","unstructured":"14. Silver K, Andermann F. Alternating Hemiplegia of Childhood: The Natural History of the Disorder in a Group of 10 Patients. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:19-28."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00041327-200206000-00007","article-title":"Ocular motor features of alternating hemiplegia of childhood","volume":"22","author":"Egan","year":"2002","unstructured":"15. Egan RA. Ocular motor features of alternating hemiplegia of childhood. J Neuroophthalmol 2002;22:99-101.","journal-title":"J Neuroophthalmol"},{"key":"ref15","unstructured":"16. Fusco L, Vigevano F. Alternating Hemiplegia of Childhood: Clinical Findings during Attacks. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:29-41."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neuroscience.2018.07.018","article-title":"A transgenic mouse model to selectively identify \u03b1(3) Na,K-ATPase expressing cells in the nervous system","volume":"398","author":"Dobretsov","year":"2019","unstructured":"17. Dobretsov M, Hayar A, Kockara NT, et al. A transgenic mouse model to selectively identify \u03b1(3) Na,K-ATPase expressing cells in the nervous system. Neuroscience 2019;398:274-94.","journal-title":"Neuroscience"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cne.22524","article-title":"Distribution of Na\/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain","volume":"519","author":"B\u00f8ttger","year":"2011","unstructured":"18. B\u00f8ttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K. Distribution of Na\/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. J Comp Neurol 2011;519:376-404.","journal-title":"J Comp Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/dmcn.14077","article-title":"Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood","volume":"61","author":"Jasien","year":"2019","unstructured":"19. Jasien JM, Bonner M, D'alli R, et al. Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood. Dev Med Child Neurol 2019;61:547-54.","journal-title":"Dev Med Child Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.eplepsyres.2010.05.013","article-title":"Evolution of hemiplegic attacks and epileptic seizures in alternating hemiplegia of childhood","volume":"90","author":"Saito","year":"2010","unstructured":"20. Saito Y, Inui T, Sakakibara T, Sugai K, Sakuma H, Sasaki M. Evolution of hemiplegic attacks and epileptic seizures in alternating hemiplegia of childhood. Epilepsy Res 2010;90:248-58.","journal-title":"Epilepsy Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/TACG.S210325","article-title":"Alternating hemiplegia of childhood: understanding the genotype-phenotype relationship of ATP1A3 variations","volume":"13","author":"Capuano","year":"2020","unstructured":"21. Capuano A, Garone G, Tiralongo G, Graziola F. Alternating hemiplegia of childhood: understanding the genotype-phenotype relationship of ATP1A3 variations. Appl Clin Genet 2020;13:71-81.","journal-title":"Appl Clin Genet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-3002(57)90343-8","article-title":"The influence of some cations on an adenosine triphosphatase from peripheral nerves","volume":"23","author":"Skou","year":"1957","unstructured":"22. Skou JC. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta 1957;23:394-401.","journal-title":"Biochim Biophys Acta"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Viollet L, Glusman G, Murphy KJ, et al. Alternating hemiplegia of childhood: retrospective genetic study and genotype-phenotype correlations in 187 subjects from the US AHCF registry. PLoS One 2015;10: e0127045.","DOI":"10.1371\/journal.pone.0127045"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.25396","article-title":"The multiple faces of the ATP1A3-related dystonic movement disorder","volume":"28","author":"Roubergue","year":"2013","unstructured":"24. Roubergue A, Roze E, Vuillaumier-Barrot S, et al. The multiple faces of the ATP1A3-related dystonic movement disorder. Mov Disord 2013;28:1457-9.","journal-title":"Mov Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pediatrneurol.2014.08.015","article-title":"Identical ATP1A3 mutation causes alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism phenotypes","volume":"51","author":"Boelman","year":"2014","unstructured":"25. Boelman C, Lagman-Bartolome AM, MacGregor DL, McCabe J, Logan WJ, Minassian BA. Identical ATP1A3 mutation causes alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism phenotypes. Pediatr Neurol 2014;51:850-3.","journal-title":"Pediatr Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1469-8749.2003.tb00899.x","article-title":"Alternating hemiplegia of childhood: a syndrome inherited with an autosomal dominant trait","volume":"45","author":"Kanavakis","year":"2003","unstructured":"26. Kanavakis E, Xaidara A, Papathanasiou-Klontza D, Papadimitriou A, Velentza S, Youroukos S. Alternating hemiplegia of childhood: a syndrome inherited with an autosomal dominant trait. Dev Med Child Neurol 2003;45:833-6.","journal-title":"Dev Med Child Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10048-016-0498-9","article-title":"Mosaicism in ATP1A3-related disorders: not just a theoretical risk","volume":"18","author":"Hully","year":"2017","unstructured":"27. Hully M, Ropars J, Hubert L, et al. Mosaicism in ATP1A3-related disorders: not just a theoretical risk. Neurogenetics 2017;18:23-8.","journal-title":"Neurogenetics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-015-0335-5","article-title":"Clinical profile of patients with ATP1A3 mutations in alternating hemiplegia of childhood-a study of 155 patients","volume":"10","author":"Panagiotakaki","year":"2015","unstructured":"28. Panagiotakaki E, De Grandis E, Stagnaro M, et al. Clinical profile of patients with ATP1A3 mutations in alternating hemiplegia of childhood-a study of 155 patients. Orphanet J Rare Dis 2015;10:123.","journal-title":"Orphanet J Rare Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"658451","DOI":"10.3389\/fneur.2021.658451","article-title":"Alternating hemiplegia of childhood: genotype-phenotype correlations in a cohort of 39 Italian patients","volume":"12","author":"Cordani","year":"2021","unstructured":"29. Cordani R, Stagnaro M, Pisciotta L, et al. Alternating hemiplegia of childhood: genotype-phenotype correlations in a cohort of 39 Italian patients. Front Neurol 2021;12:658451.","journal-title":"Front Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/ajmg.a.37808","article-title":"Recognizable facial features in patients with alternating hemiplegia of childhood","volume":"170","author":"Gurrieri","year":"2016","unstructured":"30. Gurrieri F, Tiziano FD, Zampino G, Neri G. Recognizable facial features in patients with alternating hemiplegia of childhood. Am J Med Genet A 2016; 170:2698-705.","journal-title":"Am J Med Genet A"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1212\/WNL.0000000000000102","article-title":"Genotype-phenotype correlations in alternating hemiplegia of childhood","volume":"82","author":"Sasaki","year":"2014","unstructured":"31. Sasaki M, Ishii A, Saito Y, et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology 2014;82:482-90.","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Yang X, Gao H, Zhang J, et al. ATP1A3 mutations and genotype-phenotype correlation of alternating hemiplegia of childhood in Chinese patients. PLoS One 2014;9:e97274.","DOI":"10.1371\/journal.pone.0097274"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2014.06.014","article-title":"Clinical and genetic analysis in alternating hemiplegia of childhood: ten new patients from Southern Europe","volume":"344","author":"Vila-Pueyo","year":"2014","unstructured":"33. Vila-Pueyo M, Pons R, Raspall-Chaure M, et al. Clinical and genetic analysis in alternating hemiplegia of childhood: ten new patients from Southern Europe. J Neurol Sci 2014;344:37-42.","journal-title":"J Neurol Sci"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Ishii A, Saito Y, Mitsui J, et al. Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS One 2013;8:e56120.","DOI":"10.1371\/journal.pone.0056120"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1474-4422(12)70182-5","article-title":"Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study","volume":"11","author":"Rosewich","year":"2012","unstructured":"35. Rosewich H, Thiele H, Ohlenbusch A, et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 2012;11:764-73.","journal-title":"Lancet Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ng.2358","article-title":"De novo mutations in ATP1A3 cause alternating hemiplegia of childhood","volume":"44","author":"Heinzen","year":"2012","unstructured":"36. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012;44:1030-4.","journal-title":"Nat Genet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10158-018-0221-7","article-title":"Na+\/K+ -pump and neurotransmitter membrane receptors","volume":"19","author":"Pivovarov","year":"2018","unstructured":"37. Pivovarov AS, Calahorro F, Walker RJ. Na+\/K+ -pump and neurotransmitter membrane receptors. Invert Neurosci 2018;19:1.","journal-title":"Invert Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"31972","DOI":"10.1038\/srep31972","article-title":"Cognitive deficits caused by a disease-mutation in the \u03b13 Na(+)\/ K(+)-ATPase isoform","volume":"6","author":"Holm","year":"2016","unstructured":"38. Holm TH, Isaksen TJ, Glerup S, et al. Cognitive deficits caused by a disease-mutation in the \u03b13 Na(+)\/ K(+)-ATPase isoform. Sci Rep 2016;6:31972.","journal-title":"Sci Rep"},{"key":"ref38","unstructured":"39. Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. ATP1A3-related Neurologic Disorders. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews(\u00ae). Seattle, WA: University of Washington, Seattle; 1993. https:\/\/www.ncbi.nlm.nih.gov\/books\/ NBK1115\/"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1542\/peds.47.4.675","article-title":"Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy","volume":"47","author":"Verret","year":"1971","unstructured":"40. Verret S, Steele JC. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics 1971;47:675-80.","journal-title":"Pediatrics"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 2015;8:49-68.","DOI":"10.2147\/TACG.S42772"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Rosewich H, Sweney MT, DeBrosse S, et al. Research conference summary from the 2014 international task force on ATP1A3-related disorders. Neurol Genet 2017;3:e139.","DOI":"10.1212\/NXG.0000000000000139"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1093\/brain\/awq295","article-title":"Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults","volume":"133","author":"Panagiotakaki","year":"2010","unstructured":"43. Panagiotakaki E, Gobbi G, Neville B, et al. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. Brain 2010;133:3598-610.","journal-title":"Brain"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11011-021-00772-x","article-title":"Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS","volume":"36","author":"Tetsuka","year":"2021","unstructured":"44. Tetsuka S, Ogawa T, Hashimoto R, Kato H. Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS. Metab Brain Dis 2021; 36:2181-93.","journal-title":"Metab Brain Dis"},{"key":"ref44","unstructured":"45. Shemesh A, Margolin E. Kearns-Sayre Syndrome. In: Aboubakr S, Abu-Ghosh A, Ackley WB, et al., eds. StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. https:\/\/www.ncbi.nlm.nih.gov\/ books\/NBK482341\/"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"5769837","DOI":"10.1155\/2017\/5769837","article-title":"More than a decade of misdiagnosis of alternating hemiplegia of childhood with catastrophic outcome","volume":"2017","author":"Algahtani","year":"2017","unstructured":"46. Algahtani H, Ibrahim B, Shirah B, Aldarmahi A, Abdullah A. More than a decade of misdiagnosis of alternating hemiplegia of childhood with catastrophic outcome. Case Rep Med 2017;2017:5769837.","journal-title":"Case Rep Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-9-15","article-title":"A novel recurrent mutation in ATP1A3 causes CAPOS syndrome","volume":"9","author":"Demos","year":"2014","unstructured":"47. Demos MK, van Karnebeek CD, Ross CJ, et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis 2014;9:15.","journal-title":"Orphanet J Rare Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ejpn.2019.02.004","article-title":"Arg756 in ATP1A3","volume":"23","author":"Sabouraud","year":"2019","unstructured":"48. Sabouraud P, Riquet A, Spitz M-A, et al. Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3. Eur J Paediatr Neurol 2019;23:448-55.","journal-title":"Eur J Paediatr Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"637890","DOI":"10.3389\/fneur.2021.637890","article-title":"ATP1A3-related disorders: an ever-expanding clinical spectrum","volume":"12","author":"Salles","year":"2021","unstructured":"49. Salles PA, Mata IF, Br\u00fcnger T, Lal D, Fernandez HH. ATP1A3-related disorders: an ever-expanding clinical spectrum. Front Neurol 2021;12:637890.","journal-title":"Front Neurol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ana.20134","article-title":"Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation","volume":"55","author":"Swoboda","year":"2004","unstructured":"50. Swoboda KJ, Kanavakis E, Xaidara A, et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol 2004;55:884-7.","journal-title":"Ann Neurol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1212\/WNL.44.10.1812","article-title":"Benign familial nocturnal alternating hemiplegia of childhood","volume":"44","author":"Andermann","year":"1994","unstructured":"51. Andermann E, Andermann F, Silver K, Levin S, Arnold D. Benign familial nocturnal alternating hemiplegia of childhood. Neurology 1994;44:1812-14.","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0887-8994(98)00016-2","article-title":"A case of alternating hemiplegia of childhood with cerebellar atrophy","volume":"19","author":"Saito","year":"1998","unstructured":"52. Saito Y, Sakuragawa N, Sasaki M, Sugai K, Hashimoto T. A case of alternating hemiplegia of childhood with cerebellar atrophy. Pediatr Neurol 1998;19:65-8.","journal-title":"Pediatr Neurol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.braindev.2010.08.008","article-title":"Benign nocturnal alternating hemiplegia of childhood: two cases with positive evolution","volume":"33","author":"Vill\u00e9ga","year":"2011","unstructured":"53. Vill\u00e9ga F, Picard F, Espil-Taris C, Husson M, Michel V, Pedespan J-M. Benign nocturnal alternating hemiplegia of childhood: two cases with positive evolution. Brain Dev 2011;33:525-9.","journal-title":"Brain Dev"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ejpn.2018.07.012","article-title":"Benign nocturnal alternating hemiplegia of childhood: a clinical and nomenclatural reappraisal","volume":"22","author":"RPPWM","year":"2018","unstructured":"54. Maas RPPWM, Kamsteeg E-J, Mangano S, et al. Benign nocturnal alternating hemiplegia of childhood: a clinical and nomenclatural reappraisal. Eur J Paediatr Neurol 2018;22:1110-17.","journal-title":"Eur J Paediatr Neurol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/brain\/awf132","article-title":"A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria","volume":"125","author":"Thomsen","year":"2002","unstructured":"55. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002;125:1379-91.","journal-title":"Brain"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1469-8749.2007.00777.x","article-title":"The treatment and management of alternating hemiplegia of childhood","volume":"49","author":"BGR","year":"2007","unstructured":"56. Neville BGR, Ninan M. The treatment and management of alternating hemiplegia of childhood. Dev Med Child Neurol 2007;49:777-80.","journal-title":"Dev Med Child Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"103957","DOI":"10.1016\/j.ejmg.2020.103957","article-title":"Long-term follow-up and novel genotype-phenotype analysis of monozygotic twins with ATP1A3 mutation in alternating hemiplegia of childhood-2","volume":"63","author":"Pavone","year":"2020","unstructured":"57. Pavone P, Pappalardo XG, Incorpora G, et al. Long-term follow-up and novel genotype-phenotype analysis of monozygotic twins with ATP1A3 mutation in alternating hemiplegia of childhood-2. Eur J Med Genet 2020;63:103957.","journal-title":"Eur J Med Genet"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58. Casaer P. Flunarizine in alternating hemiplegia in childhood. An international study in 12 children. Neuropediatrics 1987;18:191-5.","DOI":"10.1055\/s-2008-1052478"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2019.10.003","article-title":"Management of alternating hemiplegia of childhood: a review","volume":"103","author":"Samanta","year":"2020","unstructured":"59. Samanta D. Management of alternating hemiplegia of childhood: a review. Pediatr Neurol 2020;103:12-20.","journal-title":"Pediatr Neurol"},{"key":"ref59","unstructured":"60. Bourgeois M, Aicardi J, Andermann F, Aicardi J, Vigevano F. The Treatment of Alternating Hemiplegia in Childhood with Flunarizine. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1994:191-3."},{"key":"ref60","unstructured":"61. Sakuragawa N. The Treatment of Alternating Hemiplegia of Childhood in Japan. In: Andermann F, Aicardi J, Vigevano F, eds. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995:199."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.braindev.2017.02.001","article-title":"Alternating hemiplegia of childhood: pharmacological treatment of 30 Italian patients","volume":"39","author":"Pisciotta","year":"2017","unstructured":"62. Pisciotta L, Gherzi M, Stagnaro M, et al. Alternating hemiplegia of childhood: pharmacological treatment of 30 Italian patients. Brain Dev 2017;39:521-8.","journal-title":"Brain Dev"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-2006-924721","article-title":"Topiramate: a new agent for patients with alternating hemiplegia of childhood","volume":"37","author":"Jiang","year":"2006","unstructured":"63. Jiang W, Chi Z, Ma L, et al. Topiramate: a new agent for patients with alternating hemiplegia of childhood. Neuropediatrics 2006;37:229-33.","journal-title":"Neuropediatrics"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.7196\/SAMJ.2019.v109i3.13757","article-title":"Alternating hemiplegia of childhood: first South African case report and verapamil as a possible treatment option","volume":"109","author":"Hillegondsberg LS","year":"2019","unstructured":"64. Van Hillegondsberg LS, Michaelis IA. Alternating hemiplegia of childhood: first South African case report and verapamil as a possible treatment option. S Afr Med J 2019;109:152-3.","journal-title":"S Afr Med J"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/WNF.0000000000000420","article-title":"Intravenous immunoglobulin in the treatment of alternating hemiplegia of childhood","volume":"44","author":"Samanta","year":"2021","unstructured":"65. Samanta D, Ramakrishnaiah R. Intravenous immunoglobulin in the treatment of alternating hemiplegia of childhood. Clin Neuropharmacol 2021;44:23-6.","journal-title":"Clin Neuropharmacol"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"66. Guevara-Campos J, Gonz\u00e1lez-de Guevara L, Urb\u00e1ez-Cano J, Tinedo R, Villamizar M, Rojas L. [Alternating hemiplegia of childhood treated as epilepsy. Two new cases]. Rev Neurol 2005;40:351-3. [Article in Spanish] https:\/\/pubmed.ncbi.nlm.nih.gov\/15795871\/","DOI":"10.33588\/rn.4006.2004494"},{"key":"ref66","unstructured":"67. Zhang Y, Sun W, Qin J, Jiang Y, Wu X. [Clinical characteristics of alternating hemiplegia of childhood in 13 patients]. Zhonghua Er Ke Za Zhi 2003;41:680-3. [Article in Chinese] https:\/\/pubmed.ncbi.nlm.nih.gov\/14733811\/"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"68. Uchitel J, Helseth A, Prange L, et al. The epileptology of alternating hemiplegia of childhood. Neurology 2019;93:e1248-59.","DOI":"10.1212\/WNL.0000000000008159"},{"key":"ref68","unstructured":"69. Campos JG, Cano JU, Tinedo R, Villamizar M, De Guevara LG. Alternating hemiplegia of childhood. J Pediatr Neurol 2005;3:199-205."},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"70. Kurian MA, Dale RC. Movement disorders presenting in childhood. Continuum (Minneap Minn) 2016;22: 1159-85.","DOI":"10.1212\/CON.0000000000000367"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"71. Helseth A, Prange L, Kansagra S, Muh C, Mikati M. Effects of vagal nerve stimulation in alternating hemiplegia of childhood. Neurology 2016;86:I15001.","DOI":"10.1212\/WNL.86.16_supplement.P6.334"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"72. Camfield P, Andermann F. Successful treatment of two cases of alternating hemiplegia with acetazolamide. Neuropediatrics 2006;37:(S1).","DOI":"10.1055\/s-2006-945585"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-2000-12945","article-title":"Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood","volume":"31","author":"Sone","year":"2000","unstructured":"73. Sone K, Oguni H, Katsumori H, Funatsuka M, Tanaka T, Osawa M. Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood. Neuropediatrics 2000;31:307-9.","journal-title":"Neuropediatrics"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/WNF.0000000000000339","article-title":"An option to consider for alternating hemiplegia of childhood: aripiprazole","volume":"42","author":"Dundar","year":"2019","unstructured":"74. Dundar NO, Cavusoglu D, Kaplan YC, Hasturk MO. An option to consider for alternating hemiplegia of childhood: aripiprazole. Clin Neuropharmacol 2019; 42:88-90.","journal-title":"Clin Neuropharmacol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1469-8749.2008.03192.x","article-title":"Treatment of alternating hemiplegia of childhood with aripiprazole","volume":"51","author":"Haffejee","year":"2009","unstructured":"75. Haffejee S, Santosh PJ. Treatment of alternating hemiplegia of childhood with aripiprazole. Dev Med Child Neurol 2009;51:74-7.","journal-title":"Dev Med Child Neurol"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76. Wong VCN, Kwong AKY. ATP1A3 mutation in a Chinese girl with alternating hemiplegia of childhood--potential target of treatment? Brain Dev 2015;37:907-10.","DOI":"10.1016\/j.braindev.2015.01.003"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1090-3798(08)70745-1","article-title":"PHP015 Alternating hemiplegia of childhood with mitochondrial dysfunction: response to coenzyme Q10","volume":"11","author":"Bhatt","year":"2007","unstructured":"77. Bhatt A, DeRoos S, Chillag K. PHP015 Alternating hemiplegia of childhood with mitochondrial dysfunction: response to coenzyme Q10. Eur J Paediatr Neurol 2007;11:127-8.","journal-title":"Eur J Paediatr Neurol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.braindev.2018.01.002","article-title":"ATP1A3-related epileptic encephalopathy responding to ketogenic diet","volume":"40","author":"Schirinzi","year":"2018","unstructured":"78. Schirinzi T, Graziola F, Cusmai R, et al. ATP1A3-related epileptic encephalopathy responding to ketogenic diet. Brain Dev 2018;40:433-8.","journal-title":"Brain Dev"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79. Roubergue A, Philibert B, Gautier A, et al. Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood. JIMD Rep 2015; 15:7-12.","DOI":"10.1007\/8904_2013_292"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2013.11.017","article-title":"Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic diet","volume":"50","author":"Ulate-Campos","year":"2014","unstructured":"80. Ulate-Campos A, Fons C, Artuch R, et al. Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic diet. Pediatr Neurol 2014;50:377-9.","journal-title":"Pediatr Neurol"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"81. Korinthenberg R. Is infantile alternating hemiplegia mediated by glutamate toxicity and can it be treated with memantine? Neuropediatrics 1996;27:277-8.","DOI":"10.1055\/s-2007-973779"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-016-0438-7","article-title":"Treatment with oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 Mutation","volume":"11","author":"Ju","year":"2016","unstructured":"82. Ju J, Hirose S, Shi X-Y, Ishii A, Hu L-Y, Zou L-P. Treatment with oral ATP decreases alternating hemiplegia of childhood with de novo ATP1A3 Mutation. Orphanet J Rare Dis 2016;11:55.","journal-title":"Orphanet J Rare Dis"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/00207454.2012.683216","article-title":"Alternating hemiplegia of childhood in chinese following long-term treatment with flunarizine or topiramate","volume":"122","author":"Chi","year":"2012","unstructured":"83. Chi L, Zhao X, Liu X, Jiang W, Chi Z, Wang S. Alternating hemiplegia of childhood in chinese following long-term treatment with flunarizine or topiramate. Int J Neurosci 2012;122:506-10.","journal-title":"Int J Neurosci"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1212\/01.wnl.0000191401.37260.f5","article-title":"Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up","volume":"66","author":"Di Rosa","year":"2006","unstructured":"84. Di Rosa G, Span\u00f2 M, Pustorino G, et al. Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up. Neurology 2006; 66:146.","journal-title":"Neurology"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13023-017-0713-2","article-title":"A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood","volume":"12","author":"Hainque","year":"2017","unstructured":"85. Hainque E, Caillet S, Leroy S, et al. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood. Orphanet J Rare Dis 2017;12:160.","journal-title":"Orphanet J Rare Dis"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"86. Pavone P, Pappalardo XG, Ruggieri M, Falsaperla R, Parano E. Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: a narrative review. Medicine (Baltimore) 2022;101: e29413.","DOI":"10.1097\/MD.0000000000029413"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.43.1_Part_1.36","article-title":"Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment","volume":"43","author":"Silver","year":"1993","unstructured":"87. Silver K, Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 1993;43:36-41.","journal-title":"Neurology"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"924788","DOI":"10.3389\/fneur.2022.924788","article-title":"Molecular and clinical characteristics of ATP1A3-related diseases","volume":"13","author":"Li","year":"2022","unstructured":"88. Li Y, Liu X, Wang C, et al. Molecular and clinical characteristics of ATP1A3-related diseases. Front Neurol 2022;13:924788.","journal-title":"Front Neurol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"105012","DOI":"10.1016\/j.nbd.2020.105012","article-title":"Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity","volume":"143","author":"Lazarov","year":"2020","unstructured":"89. Lazarov E, Hillebrand M, Schr\u00f6der S, et al. Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity. Neurobiol Dis 2020; 143:105012.","journal-title":"Neurobiol Dis"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2017.04.022","article-title":"Fever-induced paroxysmal weakness and encephalopathy, a new phenotype of ATP1A3 mutation","volume":"73","author":"Yano","year":"2017","unstructured":"90. Yano ST, Silver K, Young R, et al. Fever-induced paroxysmal weakness and encephalopathy, a new phenotype of ATP1A3 mutation. Pediatr Neurol 2017;73: 101-5.","journal-title":"Pediatr Neurol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/dmcn.14666","article-title":"ATP1A3 variants and slowly progressive cerebellar ataxia without paroxysmal or episodic symptoms in children","volume":"63","author":"Sasaki","year":"2021","unstructured":"91. Sasaki M, Sumitomo N, Shimizu-Motohashi Y, et al. ATP1A3 variants and slowly progressive cerebellar ataxia without paroxysmal or episodic symptoms in children. Dev Med Child Neurol 2021;63:111-15.","journal-title":"Dev Med Child Neurol"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"92. Smedemark-Margulies N, Brownstein CA, Vargas S, et al. A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia. Cold Spring Harb Mol Case Stud 2016;2:a001008.","DOI":"10.1101\/mcs.a001008"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41380-018-0103-8","article-title":"Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia","volume":"25","author":"Chaumette","year":"2020","unstructured":"93. Chaumette B, Ferrafiat V, Ambalavanan A, et al. Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia. Mol Psychiatry 2020;25:821-30.","journal-title":"Mol Psychiatry"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/tohm.490","article-title":"Generalized dystonia and paroxysmal dystonic attacks due to a novel ATP1A3 variant","volume":"2019","author":"Z\u00fa\u00f1iga-Ram\u00edrez","year":"2019","unstructured":"94. Z\u00fa\u00f1iga-Ram\u00edrez C, Kramis-Hollands M, Mercado-Pimentel R, et al. Generalized dystonia and paroxysmal dystonic attacks due to a novel ATP1A3 variant. Tremor Other Hyperkinet Mov (N Y) 2019;2019:9.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1212\/WNL.94.15_supplement.1946","article-title":"P775L (1946)","volume":"94","author":"Calame","year":"2020","unstructured":"95. Calame D, Shinawi M, Cohen J, et al. Atypical phenotypes caused by the ATP1A3 variant p.P775L (1946). Neurology 2020;94:1946.","journal-title":"Neurology"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"96. Prange L, Pratt M, Herman K, et al. D-DEM\u00d8, a distinct phenotype caused by ATP1A3 mutations. Neurol Genet 2020;6:e466.","DOI":"10.1212\/NXG.0000000000000466"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fncel.2019.00425","article-title":"Recessive inheritance of congenital hydrocephalus with other structural brain abnormalities caused by compound heterozygous mutations in ATP1A3","volume":"13","author":"Allocco","year":"2019","unstructured":"97. Allocco AA, Jin SC, Duy PQ, et al. Recessive inheritance of congenital hydrocephalus with other structural brain abnormalities caused by compound heterozygous mutations in ATP1A3. Front Cell Neurosci 2019;13:425.","journal-title":"Front Cell Neurosci"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/brain\/awab052","article-title":"ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria","volume":"144","author":"Vetro","year":"2021","unstructured":"98. Vetro A, Nielsen HN, Holm R, et al. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. Brain 2021;144:1435-50.","journal-title":"Brain"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1073\/pnas.1108416108","article-title":"Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase \u03b13 sodium pump","volume":"108","author":"Kirshenbaum","year":"2011","unstructured":"99. Kirshenbaum GS, Clapcote SJ, Duffy S, et al. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase \u03b13 sodium pump. Proc Natl Acad Sci U S A 2011;108:18144-9.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1113\/jphysiol.2012.247817","article-title":"Enhanced inhibitory neurotransmission in the cerebellar cortex of ATP1A3-deficient heterozygous mice","volume":"591","author":"Ikeda","year":"2013","unstructured":"100. Ikeda K, Satake S, Onaka T, et al. Enhanced inhibitory neurotransmission in the cerebellar cortex of ATP1A3-deficient heterozygous mice. J Physiol 2013; 591:3433-49.","journal-title":"J Physiol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphys.2016.00209","article-title":"Insights into the pathology of the \u03b13 Na(+)\/K(+)-ATPase ion pump in neurological disorders; lessons from animal models","volume":"7","author":"Holm","year":"2016","unstructured":"101. Holm TH, Lykke-Hartmann K. Insights into the pathology of the \u03b13 Na(+)\/K(+)-ATPase ion pump in neurological disorders; lessons from animal models. Front Physiol 2016;7:209.","journal-title":"Front Physiol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"14085","DOI":"10.1073\/pnas.0904817106","article-title":"Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS","volume":"106","author":"Clapcote","year":"2009","unstructured":"102. Clapcote SJ, Duffy S, Xie G, et al. Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc Natl Acad Sci U S A 2009;106:14085-90.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nbd.2018.07.028","article-title":"Novel E815K knock-in mouse model of alternating hemiplegia of childhood","volume":"119","author":"Helseth","year":"2018","unstructured":"103. Helseth AR, Hunanyan AS, Adil S, et al. Novel E815K knock-in mouse model of alternating hemiplegia of childhood. Neurobiol Dis 2018;119:100-12.","journal-title":"Neurobiol Dis"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00439-020-02182-y","article-title":"ATP1A3 mutation as a candidate cause of autosomal dominant cone-rod dystrophy","volume":"139","author":"G-H","year":"2020","unstructured":"104. Zhou G-H, Ma Y, Li M-L, Zhou X-Y, Mou H, Jin Z-B. ATP1A3 mutation as a candidate cause of autosomal dominant cone-rod dystrophy. Hum Genet 2020;139: 1391-401.","journal-title":"Hum Genet"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1474-4422(14)70011-0","article-title":"Distinct neurological disorders with ATP1A3 mutations","volume":"13","author":"Heinzen","year":"2014","unstructured":"105. Heinzen EL, Arzimanoglou A, Brashear A, et al. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol 2014;13:503-14.","journal-title":"Lancet Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1523\/JNEUROSCI.4464-06.2007","article-title":"Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice","volume":"27","author":"Moseley","year":"2007","unstructured":"106. Moseley AE, Williams MT, Schaefer TL, et al. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 2007;27:616-26.","journal-title":"J Neurosci"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.bbr.2010.09.009","article-title":"Characterization of ATP1A3 mutant mice as a model of rapid-onset dystonia with parkinsonism","volume":"216","author":"DeAndrade","year":"2011","unstructured":"107. DeAndrade MP, Yokoi F, van Groen T, Lingrel JB, Li Y. Characterization of ATP1A3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 2011;216:659-65.","journal-title":"Behav Brain Res"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"108. Ng HWY, Ogbeta JA, Clapcote SJ. Genetically altered animal models for ATP1A3-related disorders. Dis Model Mech 2021;14:dmm0489384.","DOI":"10.1242\/dmm.048938"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1074\/jbc.M112.421529","article-title":"\u03b13Na+\/K+-ATPase deficiency causes brain ventricle dilation and abrupt embryonic motility in zebrafish","volume":"288","author":"Do\u011fanli","year":"2013","unstructured":"109. Do\u011fanli C, Beck HC, Ribera AB, Oxvig C, Lykke-Hartmann K. \u03b13Na+\/K+-ATPase deficiency causes brain ventricle dilation and abrupt embryonic motility in zebrafish. J Biol Chem 2013;288:8862-74.","journal-title":"J Biol Chem"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/1784\/0\/PublishFiles\/1784Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T08:41:16Z","timestamp":1724575276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/63\/articles\/1784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,7,30]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10529","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}